Therapeutic approaches to the management of common baldness

International Journal of Clinical Practice

Volumn 53, Issue 5, 1999, Pages 381-385

  Sommer, S ^a,b   Wilson, C ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; MINOXIDIL;

ALOPECIA; DIFFERENTIAL DIAGNOSIS; HAIR GROWTH; HAIR TRANSPLANTATION; HUMAN; MALE; MALE TYPE ALOPECIA; METABOLIC DISORDER; NUTRITIONAL DEFICIENCY; PRIORITY JOURNAL; PROSTHESIS; REVIEW; ROTATION; SCALP; SOCIAL PSYCHOLOGY; TOPICAL DRUG ADMINISTRATION;

EID: 0032802421     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Hamilton JB. Male hormone stimulation is prerequisite and an incitant in common baldness. Am J Anat 1942; 71: 451-480.
2. Hamilton JB. Effect of castration in adolescent and young adult males upon further changes in the proportion of bare and hairy scalp. J Clin Endocrinol 1960; 20: 1309-1318.
3. Giacometti L. Facts, legends and myths about the scalp throughout history. Arch Dermatol 1967; 95: 629-631.
4. Brigham PA, Cappas A, Uno H. The stump-tailed macaque as a model for androgenetic alopecia: effects of topical minoxidil analyzed by the use of the folliculogram. Clin Dermatol 1988; 6(4): 177-187.
5. Hamilton JB. Male pattern hair loss in man: types and incidence. Ann NY Acad Sci 1951; 53: 708-728.
6. Ludwig E. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 1977; 97: 247-254.
7. Simpson NB, Barth JH. Hair patterns: hirsutes and androgenetic alopecia. In Dawber RPR, Ed. Diseases of the hair and scalp. Oxford: Blackwell Science, 1991.
8. Setty LR. Hair patterns of the scalp of white and Negro males. Am J Phys Anthropol 1970; 33: 49-55.
9. Sinclair R. Male pattern androgenetic alopecia. BMJ 1998; 317: 865-869.
10. Maffei C, Fossati A, Rinaldi F et al. Personality disorder and psychopathological symptoms in patients with androgenetic alopecia. Arch Dermatol 1994; 130(7): 868-872.
11. Cash TF, Price VH, Savin RC. Psychological effects of androgenetic alopecia on women: comparisons with balding men and with female control subjects. J Am Acad Dermatol 1993; 29: 568-575.
12. Van der Donk J, Passchier J, Knegt-Junk C et al. Psychological characteristics of women with androgenetic alopecia: a controlled study. Br J Dermatol 1991; 125: 248-252.
13. Venning VA, Dawber R. Patterned androgenetic alopecia. J Am Acad Dermatol 1988; 18: 1073-1078.
14. Takashima T, Iju M, Sudo M. Alopecia androgenetica: its incidence in Japanese and associated conditions. In: Orfanos CE, Montagna W, Stüttgen G Eds. Hair research. Berlin: Springer Verlag 1981: 287.
15. Norwood O'TT. Male pattern baldness: classification and incidence. South Med J 1975; 68: 1359-1365.
16. Hibberts NA, Howell AE, Randall VA. Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp. J Endocrin 1988; 156: 59-65.
17. Kuhlwein A. Androgene Alopezie vom weiblichen Typ beim Mann. Z Hautkr 1985; 60: 576-578.
18. Bergfeld WF. Androgenetic alopecia: an autosomal dominant disorder. Am J Med 1995; 98(suppl): 95S-8S.
19. Küster W, Happle R. The inheritance of common baldness: two B or not two B? J Am Acad Dermatol 1984; 11: 921-926.
20. Smith MA, Wells RS. Male-type alopecia, alopecia areata, and normal hair in women. Arch Dermatol 1964; 89: 155-158.
21. Randall VA, Hibberts NA, Hamada K. A comparison of the culture and growth of dermal papilla cells from hair follicles from non balding and balding (androgenetic alopecia) scalp. Br J Dermatol 1996; 134: 437-444.
22. Chen W, Zouboulis CC, Orfanos CE. The 5-alpha-reductase system and its inhibitors: recent development and its perspective in treating androgen-dependent skin disorders. Dermatology 1996; 193: 177-184.
23. Pitts RL. Serum elevation of dehydroepiandrosterone sulfate associated with male pattern baldness in young men. J Am Acad Dermatol 1987; 16: 571-579.
24. Damon A, Burr WA, Gerson DE. Baldness, fertility and number and sex ratio of children. Hum Biol 1965; 37: 366-374.
25. Burton JL, Ben Halim MM, Meyrick GJ. Male pattern alopecia and masculinity. Br J Dermatol 1979; 100: 567-571.
26. De Villez RL, Dunn J. Female androgenetic alopecia. The 3,17-androstanedial glucuronide/sex hormone binding globulin ratio as a possible marker for female pattern baldness. Arch Dermatol 1986; 122: 1011.
27. Futterweit W, Dunif A, Yen H-C et al. The prevalence of hyperandrogenism in 109 consecutive female patients with diffuse alopecia. J Am Acad Dermatol 1988; 19: 831.
28. Sawaya ME, Price VH. Different levels of 5-alpha-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol 199; 109: 296-300.
29. Kligman AM. The comparative histopathology of male pattern baldness and senescent baldness. Clin Dermatol 1988; 6: 108-118.
30. Whiting DA. Diagnostic and predictive value of horizontal sections of scalp biopsy specimens in male pattern androgenetic alopecia. J Am Acad Dermatol 1993; 28: 755-763.
31. Rook A, Dawber R, Eds. Diseases of the hair and scalp, 2nd edn. Oxford: Blackwell Scientific Publications, 1991: 153-61.
32. Kligman AM. Pathologic dynamics of human hair loss: I. Telogen effluvium. Arch Dermatol 1961; 83: 175-198.
33. Whiting DA. Chronic telogen effluvium: increased scalp hair shedding in middle-aged women. J Am Acad Dermatol 1996; 35: 899-906.
34. Cash TF. The psychological effects of androgenetic alopecia in men. J Am Acad Dermatol 1992; 26: 926-931.
35. Rushton DH, Norris MJ, Ramsay ID. Topical 0.05% finasteride significantly reduced serum DHT concentrations, but had no effect in preventing the expression of genetic hair loss in men. In: Van Neste D, Randall VA, Eds. Hair research for the next millennium. Amsterdam: Elsevier 1996: 359-362.
36. Mortimer CH, Rushton H, James KC. Effective medical treatment for common baldness in women. Clin Exp Dermatol 1984; 9: 342-348.
37. Pereboom-Wynia JD, van der Willingen AH, vand Jost T et al. The effect of cyproterone acetate on hair roots and hair shaft diameter in androgenetic alopecia in women. Acta Dermatol Venereol 1989; 69: 395-398.
38. Barth JH, Cherry CA, Wojnarowska F et al. Cyproterone acetate for severe hirsutism: results of a double blind dose ranging study. J Clin Endocrinol Metab 1991; 35: 5-10.
39. Aram H. Treatment of female androgenetic alopecia with cimetidine. Int J Dermatol 1987; 26: 128-130.
40. Burke B, Cunliffe WJ. Oral spironolactone therapy for female patients with acne, hirsutism or androgenic alopecia (correspondence). Br J Dermatol 1985; 112: 124-128.
41. Barth JH, Cherry CA, Wojnarowska F et al. Spironolactone is an effective and well tolerated systemic anti-androgen therapy for hirsute women. J Clin Endocrinol Metab 1989; 68: 96-102.
42. Price V. Review of clinical data: finasteride 1 mg. Clin Dermatol 2000, Singapore 1998 (abstract).
43. Roberts J, Hordinsky M, Olsen E et al. The effect of finasteride on post-menopausal women with androgenetic alopecia. International Hair Loss Workshop, Belgium, Brussels, 1998 (abstract).
44. Vanderveen EC, Ellis CN, Kang S et al. Topical minoxidil for hair regrowth. J Am Acad Dermatol 1984; 11: 416.
45. Olsen EA, Weiner MS. Topical minoxidil in the treatment of male pattern baldness. J Am Acad Dermatol 1987; 16: 191-204.
46. Olsen EA, Weiner MS, Amara IA et al. Five-year follow-up of men with androgenetic alopecia treated with topical minoxidil. J Am Acad Dermatol 1990; 22: 643-646.
47. Wilson C, Walkden V, Powell S et al. Contact dermatitis in reaction to 2% topical minoxidil solution. J Am Acad Dermatol 1991; 24(4): 661-662.
48. Tosti A, Bardazzi F, De Padova MP et al. Contact dermatitis due to minoxidil. Cont Dermat 1985; 13: 275-277.
49. Peluso AM, Misciali C, Vincenzi C et al. Diffuse hypertrichosis during treatment with 5% topical minoxidil. Br J Dermatol 1997; 136: 118-120.
50. Orentreich N. Autografts in alopecias and other selected dermatological conditions. Ann NY Acad Sci 1959; 83: 462.
51. Bernstein RM, Rassman WR. Follicular transplantation: patient evaluation and surgical planning. Derm Surg 1997; 23: 771-784.
52. Cash TF, Butters JW. Poor body image: helping the patient to change. Med Asp Hum Sexuality 1988; 22: 67-70.